What is the brand name for Tirzepatide?
The most common brand name for Tirzepatide is Mounjaro / Zepbound.
PTCE Top 200 · #110
Tirzepatide
Mounjaro / Zepbound
Tirzepatide is the generic name for the brand-name drug Mounjaro. It is a dual gip/glp-1 receptor agonist used to treat type 2 diabetes, weight loss. On the PTCE Top 200 drug list, Tirzepatide ranks #110 and is one of the most frequently tested endocrine/diabetes medications — commonly quizzed on its brand–generic pair, drug class, and key side effects.
| Generic name | Tirzepatide |
|---|---|
| Brand name(s) | Mounjaro / Zepbound |
| Drug class | Dual GIP/GLP-1 receptor agonist |
| Class group | Endocrine/Diabetes |
| Common use | type 2 diabetes, weight loss |
| DEA schedule | Unscheduled |
| Availability | Prescription only (Rx) |
What is Tirzepatide used for?
Incretin‑based injectable used for type 2 diabetes to improve glycemic control; some tirzepatide products are also approved for chronic weight management in appropriate patients.
What drug class is Tirzepatide?
Tirzepatide is a Dual GIP/GLP-1 receptor agonist in the Endocrine/Diabetes group. Knowing the class is the fastest way to predict its uses, side effects, and the brand↔generic pairs the PTCE tests.
Common side effects of Tirzepatide
- arrow_rightNausea
- arrow_rightDiarrhea
- arrow_rightVomiting
- arrow_rightDecreased appetite
- arrow_rightConstipation
- arrow_rightAbdominal pain
Major interactions
- arrow_rightInsulin or sulfonylureas ↑ hypoglycemia risk—may need dose reduction
- arrow_rightDelays gastric emptying → can affect absorption of some oral meds (use caution with narrow‑therapeutic‑index drugs)
- arrow_rightAvoid in patients with history of MTC/MEN2; monitor for pancreatitis symptoms as clinically directed
Is Tirzepatide a controlled substance?
No. Tirzepatide is not a federally controlled substance (it is unscheduled by the DEA).
warning Boxed warning
WARNING: RISK OF THYROID C‑CELL TUMORS — caused thyroid C‑cell tumors in rats; contraindicated in patients with medullary thyroid carcinoma (MTC) or MEN2.
How to remember Tirzepatide (PTCE mnemonic)
MOUNJ-aro brings a MOUNTain of weight loss — tirzePATIDE = dual GIP/GLP-1 (stronger than Ozempic). Weekly inject, N/V; thyroid C-cell warning (boxed); pancreatitis.
lightbulb
PTCE exam tip
Tirzepatide is the DUAL GIP/GLP-1 agonist — one generic, two brands by use: Mounjaro (diabetes) vs Zepbound (weight) — with the same thyroid-tumor boxed warning as semaglutide.
Tirzepatide FAQ
What is Tirzepatide used for?
Tirzepatide is used to treat type 2 diabetes, weight loss. Incretin‑based injectable used for type 2 diabetes to improve glycemic control; some tirzepatide products are also approved for chronic weight management in appropriate patients.
What drug class is Tirzepatide?
Tirzepatide is a Dual GIP/GLP-1 receptor agonist (Endocrine/Diabetes group).
Is Tirzepatide a controlled substance?
No. Tirzepatide is not a federally controlled substance (it is unscheduled by the DEA).
Related drugs in the Endocrine/Diabetes group
Drill Tirzepatide the way the PTCE asks it
RxReflex turns the Top 200 drugs into fast flashcard rounds, a guided Learn path, pharmacy math, and 40+ cheat sheets. Free to start.
Last reviewed June 25, 2026. Educational use only — not medical advice. Verify clinical specifics with your pharmacist or a current label source such as DailyMed. RxReflex is not affiliated with or endorsed by the Pharmacy Technician Certification Board (PTCB).